6-imino-3-methyl-1,4-diphenyl-1H,4H,5H,6H-pyrano[2,3-c]pyrazole-5-carbonitrile, 97%, 250mg

2-Chloro-4,6-di(naphthalen-1-yl)-1,3,5-triazine>98.0%(GC)1g

6-Fluoro-4H-benzo[1,3]dioxine-8-carboxylic acid, 95.0%, 1g

N-(3,4-dimethoxybenzyl)benzenesulfonamide, 98%, 10mg

Ethyl 5-cyano-1H-pyrazole-3-carboxylate, 97%, 100mg

6-Bromo-2-nitropyridin-3-ol, 97.0%, 1g

1-((2R,3R,4R,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95%, 1g

5-Benzyl N-(tert-Butoxycarbonyl)-L-glutamate>98.0%(HPLC)(T)25g

4,4'-(Ethane-1,2-diyl)bis(morpholine-2,6-dione), 95.0%, 5g

Crimp caps ROTILABO® with septum, Suitable for, Ø neck outside 13 mm, Silicone/PTFE, 200 Piece(s)

4,4-Dimethyl-piperidine, 95.0%, 5g

3-Fluoro-4-hydroxybenzaldehyde, 98.0%, 5g

10-Methoxy-5H-dibenzo[b,f]azepine-5-carboxamide, 95.0%, 25g